1F Hoffmann-La Roche Ltd, Pharmaceuticals Division, Basel, Switzerland. hans-joachim.boehm@roche.com
New algorithms for computational de novo ligand design are available. Empirical scoring functions help prioritize structures, with successful applications now being reported.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: